Literature DB >> 15650802

A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease.

Shun-Yu Chi1, Kun-Chou Hsei, Shyr-Ming Sheen-Chen, Fong-Fu Chou.   

Abstract

To reduce the chance of recurrent hyperthyroidism, two methods of subtotal thyroidectomy were performed and compared. From January 1998 to December 2002, 340 patients were operated on with subtotal thyroidectomy. They were prospectively randomized into two groups. Group A included 166 patients and group B 174 patients. Group A patients had a 2.5 x 1 x 1 cm thyroid remnant on each side and group B patients had a 2.5 x 1 x 1 cm remnant on one side plus total lobectomy on the other side. Thyroid function tests including T(3), T(4), TSH, and antimicrosomal antibody (AMA) were checked preoperatively and in the follow-up period of 3 months, and later up to 26.4 +/- 1.1 months (mean +/- SE). The age, sex, duration of oral medicine, and blood loss of the two groups were not significantly different during surgery and the follow-up period. The operative time was less in group A (113 +/- 3.3 minutes) than that in group B (131 +/- 3.2 minutes) (p < 0.001). In the long-term follow-up period, recurrent hyperthyroidism was noted in 15 patients in group A and 3 patients in group B. The difference was significant (p = 0.003). Hypothyroidism was noted in 35 of the group A patients and in 46 of the group B patients. The differences between the two groups regarding hypothyroidism was not significant (p = 0.181). Multivariate logistic regression analysis revealed preoperative titers of AMA > or = 6400, which was the only factor affecting the incidence of hypothyroidism in the later follow-up period. In consideration of hypothyroidism, recurrent hyperthyroidism, and postoperative complications, subtotal thyroidectomy with total lobectomy plus subtotal lobectomy provides a better outcome than bilateral subtotal lobectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15650802     DOI: 10.1007/s00268-004-7529-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

1.  The efficacy of thyroidectomy for Graves' disease: A meta-analysis.

Authors:  T K Palit; C C Miller; D M Miltenburg
Journal:  J Surg Res       Date:  2000-05-15       Impact factor: 2.192

Review 2.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

3.  Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

4.  Surgery for recurrent goitre: its complications and their risk factors.

Authors:  P E Müller; R Jakoby; G Heinert; F Spelsberg
Journal:  Eur J Surg       Date:  2001-11

5.  The surgical treatment of Graves' disease.

Authors:  F Menegaux; T Ruprecht; J P Chigot
Journal:  Surg Gynecol Obstet       Date:  1993-03

6.  Follow-up evaluation of thyroid function after thyroidectomy for thyrotoxicosis.

Authors:  T Harada; K Shimaoka; S Arita; Y Nakanishi
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

7.  Surgical treatment of hyperthyroidism: a ten-year experience.

Authors:  P Werga-Kjellman; J Zedenius; L Tallstedt; F Träisk; G Lundell; G Wallin
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

Review 8.  Diagnosis and management of thyrotoxicosis.

Authors:  J V Hennessey
Journal:  Am Fam Physician       Date:  1996-09-15       Impact factor: 3.292

9.  Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.

Authors:  K Sugino; T Mimura; K Toshima; H Iwabuchi; Y Kitamura; M Kawano; O Ozaki; K Ito
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

10.  Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.

Authors:  T Okamoto; Y Fujimoto; T Obara; Y Ito; M Aiba
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more
  6 in total

1.  Alternating from subtotal thyroid resection to total thyroidectomy in the treatment of Graves' disease prevents recurrences but increases the frequency of permanent hypoparathyroidism.

Authors:  Johannes Järhult; Per-Olof Andersson; Linda Duncker
Journal:  Langenbecks Arch Surg       Date:  2011-12-09       Impact factor: 3.445

2.  Risk factors for neck hematoma after thyroid or parathyroid surgery: ten-year analysis of the nationwide inpatient sample database.

Authors:  Ahmed Dehal; Ali Abbas; Farabi Hussain; Samir Johna
Journal:  Perm J       Date:  2015

3.  Thyroid function after subtotal thyroidectomy in patients with Graves' hyperthyroidism.

Authors:  E J Limonard; P H Bisschop; E Fliers; E J Nieveen van Dijkum
Journal:  ScientificWorldJournal       Date:  2012-02-01

4.  The value of total thyroidectomy as the definitive treatment for Graves' disease: A single centre experience of 594 cases.

Authors:  Calogero Cipolla; Giuseppa Graceffa; Sergio Calamia; Eugenio Fiorentino; Gianni Pantuso; Salvatore Vieni; Mario Latteri
Journal:  J Clin Transl Endocrinol       Date:  2019-02-07

5.  Short-Term Outcomes of Surgery for Graves' Disease in Germany.

Authors:  Elisabeth Maurer; Christian Vorländer; Andreas Zielke; Cornelia Dotzenrath; Moritz von Frankenberg; Hinrich Köhler; Kerstin Lorenz; Theresia Weber; Joachim Jähne; Antonia Hammer; Knut A Böttcher; Katharina Schwarz; Carsten Klinger; Heinz J Buhr; Detlef K Bartsch
Journal:  J Clin Med       Date:  2020-12-11       Impact factor: 4.241

Review 6.  Total or near-total thyroidectomy versus subtotal thyroidectomy for multinodular non-toxic goitre in adults.

Authors:  Roberto Cirocchi; Stefano Trastulli; Justus Randolph; Salvatore Guarino; Giorgio Di Rocco; Alberto Arezzo; Vito D'Andrea; Alberto Santoro; Marcin Barczyñski; Nicola Avenia
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.